Faraguna M, Crescitelli V, Fornari A, Barzaghi S, Savasta S, Foiadelli T
Genes (Basel). 2023; 14(2).
PMID: 36833288
PMC: 9957524.
DOI: 10.3390/genes14020362.
Schlaeger S, Sollmann N, Zoffl A, Becherucci E, Weidlich D, Kottmaier E
Diagnostics (Basel). 2021; 11(6).
PMID: 34201303
PMC: 8230029.
DOI: 10.3390/diagnostics11061056.
Greve T, Burian E, Zoffl A, Feuerriegel G, Schlaeger S, Dieckmeyer M
Quant Imaging Med Surg. 2021; 11(6):2610-2621.
PMID: 34079727
PMC: 8107331.
DOI: 10.21037/qims-20-1098.
Vaeggemose M, Mencagli R, Hansen J, Drager B, Ringgaard S, Vissing J
PeerJ. 2021; 9:e10928.
PMID: 33996274
PMC: 8106912.
DOI: 10.7717/peerj.10928.
Reyes-Leiva D, Alonso-Perez J, Mayos M, Nunez-Peralta C, Llauger J, Belmonte I
Front Neurol. 2021; 12:621257.
PMID: 33732206
PMC: 7957052.
DOI: 10.3389/fneur.2021.621257.
Restoring the regenerative balance in neuromuscular disorders: satellite cell activation as therapeutic target in Pompe disease.
Schaaf G, Canibano-Fraile R, van Gestel T, van der Ploeg A, Pijnappel W
Ann Transl Med. 2019; 7(13):280.
PMID: 31392192
PMC: 6642939.
DOI: 10.21037/atm.2019.04.48.
Advances in Quantitative Imaging of Genetic and Acquired Myopathies: Clinical Applications and Perspectives.
Paoletti M, Pichiecchio A, Piccinelli S, Tasca G, Berardinelli A, Padovani A
Front Neurol. 2019; 10:78.
PMID: 30804884
PMC: 6378279.
DOI: 10.3389/fneur.2019.00078.
Whole-body MRI and pathological findings in adult patients with myopathies.
Tomas X, Milisenda J, Garcia-Diez A, Prieto-Gonzalez S, Faruch M, Pomes J
Skeletal Radiol. 2018; 48(5):653-676.
PMID: 30377729
DOI: 10.1007/s00256-018-3107-1.
Muscle MRI in muscular dystrophies.
Diaz-Manera J, Llauger J, Gallardo E, Illa I
Acta Myol. 2016; 34(2-3):95-108.
PMID: 27199536
PMC: 4859076.
Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
Peng S, Hwu W, Lee N, Tsai F, Tsai W, Chien Y
Orphanet J Rare Dis. 2016; 11(1):63.
PMID: 27183828
PMC: 4869381.
DOI: 10.1186/s13023-016-0446-7.
Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy.
Gruhn K, Heyer C, Guttsches A, Rehmann R, Nicolas V, Schmidt-Wilcke T
Mol Genet Metab Rep. 2016; 3:58-64.
PMID: 26937398
PMC: 4750633.
DOI: 10.1016/j.ymgmr.2015.03.010.
Bioimpedance Analysis as a Method to Evaluate the Proportion of Fatty and Muscle Tissues in Progressive Myopathy in Pompe Disease.
Rozdzynska-Swiatkowska A, Jurkiewicz E, Tylki-Szymanska A
JIMD Rep. 2015; 26:45-51.
PMID: 26253708
PMC: 4864712.
DOI: 10.1007/8904_2015_473.
A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.
Parenti G, Fecarotta S, la Marca G, Rossi B, Ascione S, Donati M
Mol Ther. 2014; 22(11):2004-12.
PMID: 25052852
PMC: 4429731.
DOI: 10.1038/mt.2014.138.
Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman E, van der Pol W, Nievelstein R, Houten S, Wijburg F, Visser G
J Inherit Metab Dis. 2013; 37(3):405-13.
PMID: 24305961
DOI: 10.1007/s10545-013-9666-3.
Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.
Remiche G, Ronchi D, Magri F, Lamperti C, Bordoni A, Moggio M
J Neurol. 2013; 261(1):83-97.
PMID: 24158270
DOI: 10.1007/s00415-013-7137-2.
Double trouble in a patient with myotonia.
Hehir M, Logigian E, Raja Rayan D, Ciafaloni E
BMJ Case Rep. 2013; 2013.
PMID: 23417379
PMC: 3604294.
DOI: 10.1136/bcr-2012-008167.
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study.
van der Beek N, de Vries J, Hagemans M, Hop W, Kroos M, Wokke J
Orphanet J Rare Dis. 2012; 7:88.
PMID: 23147228
PMC: 3551719.
DOI: 10.1186/1750-1172-7-88.
Qualitative and quantitative skeletal muscle ultrasound in late-onset acid maltase deficiency.
Zaidman C, Malkus E, Siener C, Florence J, Pestronk A, Al-Lozi M
Muscle Nerve. 2011; 44(3):418-23.
PMID: 21755514
PMC: 3193541.
DOI: 10.1002/mus.22088.
Adult onset glycogen storage disease type II (adult onset Pompe disease): report and magnetic resonance images of two cases.
Del Gaizo A, Banerjee S, Terk M
Skeletal Radiol. 2009; 38(12):1205-8.
PMID: 19771425
DOI: 10.1007/s00256-009-0797-4.
Imaging and skeletal muscle disease.
Olsen N, Qi J, Park J
Curr Rheumatol Rep. 2005; 7(2):106-14.
PMID: 15760589
DOI: 10.1007/s11926-005-0062-3.